PLRX – pliant therapeutics, inc. (US:NASDAQ)
Stock Stats
News
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
Pliant Therapeutics, Inc. (NASDAQ: PLRX) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc- PLRX
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its price target lowered by analysts at Citigroup Inc. from $4.00 to $1.50. They now have a "neutral" rating on the stock.
Form SCHEDULE 13D PLIANT THERAPEUTICS, Filed by: TANG CAPITAL MANAGEMENT LLC
Form SCHEDULE 13G/A PLIANT THERAPEUTICS, Filed by: FMR LLC
Form S-8 PLIANT THERAPEUTICS,
Form 10-K PLIANT THERAPEUTICS, For: Dec 31
Form 8-K PLIANT THERAPEUTICS, For: Mar 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.